Searching:
Search by keyword, patent number, inventor, assignee, city or state:
| Patent # | Description |
|---|---|
| US-5,567,750 |
Redispersible dispersion powder composition The invention provides a redispersibte dispersion powder composition comprising a) a base polymer selected from the group consisting of vinyl ester polymers,... |
| US-5,567,749 |
Semiconductor device-encapsulating epoxy resin composition A semiconductor-encapsulating composition comprised of (i) an epoxy resin preferably containing a bifunctional biphenyl-skeletal epoxy resin and/or a... |
| US-5,567,748 |
Water compatible amine terminated resin useful for curing epoxy resins A water miscible or soluble amine terminated resin useful as a curing agent comprising the reaction product of: A) a polyamine component comprising one or more... |
| US-5,567,747 |
Water-based printing ink The invention relates to a water-based oxidizing printing ink especially suited for flexographic printing. The ink comprises an epoxy ester resin, an inorganic... |
| US-5,567,746 |
Moldable ferromagnetic particles and method Moldable ferromagnetic particles and method of making a magnetizable molding therefrom. The ferromagnetic particles are spray-coated with a slurry comprising... |
| US-5,567,745 |
Acrylic sheet having uniform distribution of coloring and mineral filler
before and after thermoforming Ranges of chain-transfer agents, thixotropic agents, and alumina trihydrate content are balanced to minimize migration or maldistribution of coloring matter and... |
| US-5,567,744 |
High water-absorbent resin composition The present invention is concerned with a high water-absorbent resin composition, produced by forming a composite by fusing or fixing a thermoplastic resin onto... |
| US-5,567,743 |
Reclamation of ester-cured phenolic resin bonded foundry sands This invention relates to a process for reclaiming ester-cured phenolic resin bonded sand. The process comprises contacting attrition reclaimed sand with a... |
| US-5,567,742 |
Dimensionally-stable polypropylene foam expanded with inorganic blowing
agents Disclosed is a low density, dimensionally-stable, extruded propylene polymer foam comprising primarily of an expanded propylene polymer material wherein the foam... |
| US-5,567,741 |
Aerated anaerobic compositions with enhanced bulk stability A storage stable anaerobic composition which does not require constant aeration with a viscosity between 50,000 to 5,000,000 mPa.s and a volume expansion of... |
| US-5,567,740 |
Conductive polyurethane foam compositions and method for producing same The present invention relates to three-dimensional expanded polyurethane foam materials, such as flexible reticulated polyurethane foam compositions, that are... |
| US-5,567,739 |
Insulating foam of low thermal conductivity and method of preparation Insulating foam for refrigerators and the like is prepared by blowing in the presence of carbon dioxide as the sole or principal blowing agent. The thermal... |
| US-5,567,738 |
Use of 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-Naphthoquinone for
the treatment of cancer The present invention relates to the use of 2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone or a physiologically acceptable salt or other... |
| US-5,567,736 |
Use of a choline salt to inhibit fatty liver in patients receiving total
parenteral nutrition Choline is added as a supplement to nutrient solutions used in total parenteral nutrition. Addition of choline to the TPN solution maintains plasma-free choline... |
| US-5,567,735 |
Therapeutic amides Amides having formula I: ##STR1## wherein E, X, R.sup.2 and R.sup.3 have the meanings given in the specification, and pharmaceutically acceptable salts and... |
| US-5,567,734 |
Phenyl-substituted alkylcarboguanidides carrying perfluoroalkyl groups,
a process for their preparation, their... Phenyl-substituted alkylcarboguanidides carrying perfluoroalkyl groups, of the formula I ##STR1## are described where R(A) and R(B) are H, Hal, CN, OR(6),... |
| US-5,567,733 |
Irritation relief using nonsteroidal anti-inflammatory compounds A method of relieving irritation to a patient's mucous membrane is provided and comprises contacting the mucous membrane with a non-steroidal anti-inflammatory... |
| US-5,567,732 |
Eicosapentaenoic acid-containing oil and methods for its production This invention describes a process for producing single cell edible oils containing eicosapentaenoic acid (EPA) from heterotrophic diatoms. The diatoms are... |
| US-5,567,731 |
Gaba-ergic modulation of eye growth A composition for the inhibition of the abnormal postnatal axial growth of the eye of a maturing animal which comprises a pharmaceutically effective amount of a... |
| US-5,567,730 |
Method of stabilizing an .omega.-3 unsaturated fatty acid compound A method of stabilizing .omega.-3 unsaturated fatty acid compounds comprising dispersing one or more compounds selected from a group consisting of an .omega.-3... |
| US-5,567,729 |
Farnesyl compounds as farnesyl protein transferase inhibitors to treat
ras induced tumor growth Farnesyl derivatives, particularly farnesyl acetate, are used to reduce the level of protein farnesylation in a mammalian host. The activity of proteins which... |
| US-5,567,728 |
Receptor ligands Use of a compound selected from the group consisting of 3,5-diiodo-4-(2-N, N-diethylaminoethoxy)phenyl-(2-butylbenzofur-3-yl)methanol hydrochloride (001), ... |
| US-5,567,726 |
Imidazole, Triazole and tetrazole derivatives Imidazole, triazole and tetrazole derivatives of formula (I) are selective agonists of 5-HT.sub.1 -like receptors and are therefore useful in the treatment of... |
| US-5,567,725 |
Substituted cyclohexanol esters, their use for treating diseases, and
pharmaceutical preparations Cyclohexanol esters of the formula I ##STR1## are described in which the radicals have the given meaning. The compounds are pharmacologically active and may... |
| US-5,567,724 |
Alkaline and acid phosphatase inhibitors in treatment of neurological
disorders The present invention provides a method of inhibiting .beta.-amyloid toxicity in brain cells. The method includes administering to the cells an amount of an... |
| US-5,567,723 |
Miticidal hydrazine compounds and their intermediates Compounds having the structural formula ##STR1## wherein R is C.sub.1 -C.sub.6 alkoxy or C.sub.1 -C.sub.6 alkyl; R.sup.1 is fluorenyl, thienyl, pyridyl or... |
| US-5,567,722 |
Cyanoguanidines as K-channel blockers Cyanoguanidine compounds of Formula I and its pharmaceutically acceptable acid addition salts ##STR1## wherein R.sub.1 is hydrogen or methyl; R.sub.2 is... |
| US-5,567,721 |
Di(aromatic) compounds and their use in human and veterinary medicine
and in cosmetics Di(aromatic) compounds corresponding to the following formula: ##STR1## in which: Ar represents either ##STR2## n=1 or 2 or: ##STR3## X... |
| US-5,567,720 |
Pharmaceutically active agents that impede amyloid formation in vivo Dense microspheres can be extracted and purified to substantial homogeneity from mammalian brain tissue, and used in the screening of therapies for potential... |
| US-5,567,719 |
Thiadiazoles and their use as antipicornaviral agents The invention pertains to heterocycle substituted phenoxyalkylheterocycles of the formula ##STR1## wherein Thi, Y, R.sub.1, R.sub.2 and R.sub.3 are as... |
| US-5,567,718 |
2,3-dihydro-1h-isoindole derivatives and their use as serotonin reuptake
inhibitors 2,3-dihydro-1H-isoindole derivatives of the formula ##STR1## where R.sub.1 -R.sub.5 and X are defined herein which are useful as serotonin reuptake... |
| US-5,567,717 |
Heterocycle substituted phenoxyalkylheterocycles and their use as
antiviral agents A compound of the formula ##STR1## wherein Y, R.sub.1, R.sub.2, R.sub.3, R.sub.4 and R.sub.5 are as defined in the specification. |
| US-5,567,716 |
Trans and cis traumatic acid salts having cicatrizant activity
associated to bacteriostatic, antiviral,... Traumatic acid salts, wherein B is a cation selected from: a) a quaternary ammonium, b) a cation of a linear or branched C.sub.1 -C.sub.20 mono-, di- or ... |
| US-5,567,715 |
Methods of treating depression by inhibiting physiological conditions
associated with an excess of neuropeptide Y A method of inhibiting a physiological disorder associated with an excess of neuropeptide Y or its symptoms comprising administering to a human in need thereof... |
| US-5,567,714 |
Methods of treating obesity by inhibiting physiological conditions
associated with an excess of neuropeptide Y A method of inhibiting obesity, a physiological disorder associated with an excess of neuropeptide Y, or its symptoms comprising administering to a human in need... |
| US-5,567,713 |
Hypoglycemic agents The present invention provides a method for treating hyperglycemia in mammals by administering an antiestrogen compound and pharmaceutically acceptable salts and... |
| US-5,567,712 |
Naphthyl compounds, intermediates, compositions and methods The present invention provides pharmaceutically active compounds formula I ##STR1## wherein R.sup.1 is --H, --OH, --O(C.sub.1 -C.sub.4 alkyl), --OCOC.sub.6 ... |
| US-5,567,711 |
Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet
activating factor antagonists The present invention provides compounds of formula ##STR1## and the pharmaceutically acceptable salts thereof which are potent antagonists of PAF and are... |
| US-5,567,710 |
Polycyclic fused ring modulators of acetylcholine receptors In accordance with the present invention, there is provided a class of polycyclic fused ring compounds which are modulators of acetylcholine receptors. The... |
| US-5,567,709 |
Carbamates of rapamycin A compound of the structure ##STR1## wherein R and R.sup.1 are each, independently, hydrogen, ##STR2## R.sup.2 and R.sup.3 are each, independently,... |
| US-5,567,708 |
Methods of treating androgenic alopecia with finasteride
... 17.beta.-N-monosubstituted-carbamoyl-4-5.alpha.-androst-1-en-3-ones of the formula ##STR1## wherein R.sup.1 is selected from hydrogen, methyl and ethyl and... |
| US-5,567,707 |
Acronycine analogues Compounds of formula (I): ##STR1## wherein R.sub.3, R.sub.4, R.sub.5, R.sub.6, X and Y are defined in the description. Those compounds are used... |
| US-5,567,706 |
Method for treating impotence A method of treating impotency in men using a pharmaceutical composition having an effective amount for treating impotency of a selective post-synaptic... |
| US-5,567,705 |
Microbicides Mixtures of certain triazole fungicides (component I) and 4-cyclopropyl-6-methyl-N-phenyl-2-pyrimidinamine (component II) have a synergistically increased... |
| US-5,567,704 |
R-enatiomerically pure hydroxylated xanthine compounds to treat baldness There is disclosed compounds and pharmaceutical compositions that are a resolved R or S (preferably R) enantiomer of an .omega.-1 alcohol of a straight chain... |
| US-5,567,703 |
Method for treating HIV infections with dideoxycarbocyclic nucleosides A therapeutic method is provided, employing an antiviral compound of the general formula: ##STR1## wherein Z is H, OR' or N(R).sub.2, wherein R' is H,... |
| US-5,567,702 |
Combination of pyrimidine derivatives and retinoids, as separate
components, for inducing and stimulating hair... Combination of pyrimidine derivatives and retinoids, as separate components, for inducing and stimulating hair growth and reducing its loss. Combination designed... |
| US-5,567,701 |
Alkylpolyglycoside and pyrimidine derivative based composition for
inducing and stimulating hair growth and/or... A composition for inducing and stimulating hair growth and/or reducing hair loss comprises at least one alkylpolyglycoside and at least one compound having... |
| US-5,567,700 |
Therapeutic heterocycles which antagonize neurokinin receptors Compounds of formula I ##STR1## wherein G, J, L, M, m and D have any of the meanings given in the specification, their N-oxides, and their pharmaceutically... |
| US-5,567,699 |
Thiadiazinone derivatives This invention provides thiadiazinone derivatives represented by the following formula (I) ##STR1## wherein R.sup.1 represents a hydrogen atom or C.sub.1... |
Copyright 2008−2012 Patents.com
